Does treatment with rosiglitazone result in improved pancreatic beta-cell function as compared to glimepiride in metformin treated diabetes type 2 patients?
Phase of Trial: Phase II
Latest Information Update: 17 Nov 2009
At a glance
- Drugs Glimepiride; Rosiglitazone
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 17 Nov 2009 New source identified and integrated (Netherlands Trial Register; NTR605)
- 08 Nov 2006 New trial record.